The growth hormone–releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line

Marta Annunziata, Cristina Grande, Francesca Scarlatti, Francesco Deltetto, Elena Delpiano, Marco Camanni, Ezio Ghigo, Riccarda Granata
Fertility and sterility · 2009 · vol. 94(3) , pp. 841–849 · doi:10.1016/j.fertnstert.2009.03.093 · PMID:19524226 · W2149480204
article OA: bronze CC0 ⤵ 4 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 was found to inhibit the proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Cell Proliferation Choristoma Endometriosis Growth Hormone-Releasing Hormone Stromal Cells Uterine Diseases Adult Cell Line, Transformed Cell Proliferation Cells, Cultured Cell Survival Cell Survival Choristoma Choristoma Choristoma Drug Evaluation, Preclinical Endometriosis Endometriosis Endometriosis Endometrium

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:05.573375+00:00
License: CC0 · commercial use OK